Report overview
This report contains market size and forecasts of NASH Therapeutic Drugs in Global, including the following market information:
Global NASH Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global NASH Therapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vitamin E and Pioglitazone Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of NASH Therapeutic Drugs include Allergan Plc (Tobira), Bristol Myers Squibb, Galmed Pharmaceuticals, Genfit SA, Gilead Sciences, Inc., Intercept Pharmaceuticals, Inc. and Zydus Cadila, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the NASH Therapeutic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global NASH Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global NASH Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
Vitamin E and Pioglitazone
Ocaliva
Elafibranor
Selonsertib and Cenicriviroc
Global NASH Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global NASH Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Online Provider
Retail Pharmacy
Global NASH Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global NASH Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies NASH Therapeutic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies NASH Therapeutic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc (Tobira)
Bristol Myers Squibb
Galmed Pharmaceuticals
Genfit SA
Gilead Sciences, Inc.
Intercept Pharmaceuticals, Inc.
Zydus Cadila
